Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
Dengler
T J
TJ
Department of Cardiology, University of Heidelberg, Germany.
Szabo
G
G
Amann
K
K
Nottmeyer
W
W
Vahl
C
C
Hagl
S
S
Zimmermann
R
R
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018801:CD2 Antigens / Q000276:immunology*; D016516:CD4-CD8 Ratio; D003327:Coronary Disease / Q000473:pathology / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D018801:CD2 Antigens; D007166:Immunosuppressive Agents; C112333:OX-34 monoclonal antibody; D016572:Cyclosporine